TAMPA, FL / ACCESSWIRE / April 25, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the first quarter 2023, after market close on May 8, 2023. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.
In addition, management will host a conference call on Monday, May 8, 2023, at 5:00 p.m. Eastern time to discuss TRxADE HEALTH's first quarter 2023 financial results. The call will conclude with a Q&A from participants. To participate, please use the following information:
Q1 2023 Conference Call and Webcast
Date: Monday, May 8, 2023
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-877-425-9470
International Dial-in: 1-201-389-0878
Webcast: https://callme.viavid.com/viavid/?callme=true&passcode=13711397&h=true&info=company&r=true&B=6
Participants can use Guest dial-in #s above and be answered by an operator
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
A playback of the call will be available through June 8, 2023. To listen, call 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally and enter replay pin number 13738429. A webcast will also be available for 30 days on the IR section of the Trxade Group website or by clicking the webcast link above.
About TRxADE HEALTH, INC.
TRxADE HEALTH (NASDAQ: MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving approximately 14,500+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For more information on TRxADE HEALTH, please visit the Company's IR website at investors.trxadegroup.com.
Investor Relations:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investors.trxadegroup.com
| Last Trade: | US$8.00 |
| Daily Volume: | 7,269 |
July 26, 2024 October 12, 2023 August 22, 2023 | |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
